Active, not recruitingPhase 3NCT06649721
Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort
Studying Primary pulmonary tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Huashan Hospital
- Intervention
- bedaquiline(drug)
- Enrollment
- 120 target
- Eligibility
- 12 years · All sexes
- Timeline
- 2024 – 2027
Study locations (30)
- Anhui Chest Hospital, Hefei, Anhui, China
- The 8th Medical Center of Chinese PLA General Hospital, Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
- The Fourth People's Hospital of Nanning, Nanning, Guangxi, China
- Liupanshui Third People's Hospital, Liupanshui, Guizhou, China
- Hebei Chest Hospital, Shijiazhuang, Hebei, China
- The Fifth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China
- Infectious Disease Hospital of Heilongjiang Province, Harbin, Heilongjiang, China
- Jiamusi Tuberculosis Hospital(Jiamusi Cancer Hospital), Jiamusi, Heilongjiang, China
- Harbin Chest Hospital, Harbin, Helongjiang, China
- Luoyang Center Hospital, Luoyang, Henan, China
- The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China
- Henan Chest Hospital, Zhengzhou, Henan, China
- Henan Infectious Disease Hospital, Zhengzhou, Henan, China
- Wuhan Pulmonary Hospital，Wuhan Tuberculosis Prevention and Control Institute, Wuhan, Hubei, China
- +15 more locations on ClinicalTrials.gov
Collaborators
Beijing Chest Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06649721 on ClinicalTrials.govOther trials for Primary pulmonary tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07484490Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in TuberculosisRiphah International University
- RECRUITINGPHASE3NCT07209761A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisOtsuka Pharmaceutical Development & Commercialization, Inc.
- RECRUITINGPHASE2NCT07170800A Phase 2b Clinical Study of JDB0131 Benzenesulfonate TabletsWestVac Biopharma Co., Ltd.
- RECRUITINGPHASE2NCT06192160Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGPHASE2NCT06748937A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With EthionamideTASK Applied Science
- ACTIVE NOT RECRUITINGNANCT07186478I-FALMIN Albumin Supplement for Patients With Pulmonary TuberculosisHasanuddin University
- RECRUITINGPHASE4NCT06476210The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)Beijing Chest Hospital
- RECRUITINGPHASE2NCT06114628Platform Assessing Regimens and Durations In a Global Multisite Consortium for TBUniversity College, London